- Home
- TENX vs SRTS Comparison
TENX vs SRTS Comparison
Compare TENX & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TENX | SRTS |
|---|---|---|
| Founded | 1967 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.2M | 65.5M |
| IPO Year | 2001 | 2016 |
Fundamental Metrics
Financial Performance| Metric | TENX | SRTS |
|---|---|---|
| Price | $14.33 | $4.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $29.67 | $7.00 |
| AVG Volume (30 Days) | ★ 474.0K | 40.2K |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $27,482,000.00 |
| Revenue This Year | N/A | $2.00 |
| Revenue Next Year | N/A | $34.23 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.64 | $3.03 |
| 52 Week High | $18.38 | $5.92 |
Technical Indicators
Market Signals| Indicator | TENX | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 49.50 | 43.97 |
| Support Level | $12.71 | $3.66 |
| Resistance Level | $16.61 | $4.71 |
| Average True Range (ATR) | 1.14 | 0.29 |
| MACD | -0.16 | 0.01 |
| Stochastic Oscillator | 28.57 | 33.33 |
Price Performance
Historical ComparisonAbout TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.